nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—Salivation—Irinotecan—colon cancer	0.029	0.029	CcSEcCtD
Tinidazole—Chromaturia—Capecitabine—colon cancer	0.021	0.021	CcSEcCtD
Tinidazole—Drug hypersensitivity—Capecitabine—colon cancer	0.0187	0.0187	CcSEcCtD
Tinidazole—Menorrhagia—Vincristine—colon cancer	0.0156	0.0156	CcSEcCtD
Tinidazole—Numbness—Vincristine—colon cancer	0.0139	0.0139	CcSEcCtD
Tinidazole—Sensory loss—Vincristine—colon cancer	0.0133	0.0133	CcSEcCtD
Tinidazole—Numbness—Fluorouracil—colon cancer	0.013	0.013	CcSEcCtD
Tinidazole—Sensory loss—Fluorouracil—colon cancer	0.0124	0.0124	CcSEcCtD
Tinidazole—Blood bilirubin increased—Irinotecan—colon cancer	0.0119	0.0119	CcSEcCtD
Tinidazole—Oral candidiasis—Capecitabine—colon cancer	0.0118	0.0118	CcSEcCtD
Tinidazole—Haemoglobin decreased—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Tinidazole—Salivary hypersecretion—Irinotecan—colon cancer	0.0109	0.0109	CcSEcCtD
Tinidazole—Coma—Vincristine—colon cancer	0.0105	0.0105	CcSEcCtD
Tinidazole—Coma—Fluorouracil—colon cancer	0.00982	0.00982	CcSEcCtD
Tinidazole—Vaginal discharge—Methotrexate—colon cancer	0.00919	0.00919	CcSEcCtD
Tinidazole—Burning sensation—Methotrexate—colon cancer	0.00805	0.00805	CcSEcCtD
Tinidazole—Blood bilirubin increased—Capecitabine—colon cancer	0.00794	0.00794	CcSEcCtD
Tinidazole—Ataxia—Vincristine—colon cancer	0.00787	0.00787	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00754	0.00754	CcSEcCtD
Tinidazole—Ataxia—Fluorouracil—colon cancer	0.00734	0.00734	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00734	0.00734	CcSEcCtD
Tinidazole—Cramp muscle—Irinotecan—colon cancer	0.00734	0.00734	CcSEcCtD
Tinidazole—Candida infection—Capecitabine—colon cancer	0.00717	0.00717	CcSEcCtD
Tinidazole—Dysuria—Vincristine—colon cancer	0.00676	0.00676	CcSEcCtD
Tinidazole—Neutropenia—Vincristine—colon cancer	0.00676	0.00676	CcSEcCtD
Tinidazole—Neutropenia—Irinotecan—colon cancer	0.00659	0.00659	CcSEcCtD
Tinidazole—Neuropathy peripheral—Vincristine—colon cancer	0.00632	0.00632	CcSEcCtD
Tinidazole—Stomatitis—Vincristine—colon cancer	0.00629	0.00629	CcSEcCtD
Tinidazole—Sweating—Vincristine—colon cancer	0.00618	0.00618	CcSEcCtD
Tinidazole—Stomatitis—Irinotecan—colon cancer	0.00612	0.00612	CcSEcCtD
Tinidazole—Glossitis—Methotrexate—colon cancer	0.00607	0.00607	CcSEcCtD
Tinidazole—Sweating—Irinotecan—colon cancer	0.00602	0.00602	CcSEcCtD
Tinidazole—Neuropathy peripheral—Fluorouracil—colon cancer	0.0059	0.0059	CcSEcCtD
Tinidazole—Stomatitis—Fluorouracil—colon cancer	0.00586	0.00586	CcSEcCtD
Tinidazole—Urinary tract infection—Fluorouracil—colon cancer	0.00585	0.00585	CcSEcCtD
Tinidazole—Hypoaesthesia—Vincristine—colon cancer	0.00576	0.00576	CcSEcCtD
Tinidazole—Thirst—Capecitabine—colon cancer	0.00573	0.00573	CcSEcCtD
Tinidazole—Urinary tract disorder—Vincristine—colon cancer	0.00572	0.00572	CcSEcCtD
Tinidazole—Urethral disorder—Vincristine—colon cancer	0.00567	0.00567	CcSEcCtD
Tinidazole—Arthritis—Capecitabine—colon cancer	0.00561	0.00561	CcSEcCtD
Tinidazole—Hypoaesthesia—Fluorouracil—colon cancer	0.00537	0.00537	CcSEcCtD
Tinidazole—Pharyngitis—Fluorouracil—colon cancer	0.00536	0.00536	CcSEcCtD
Tinidazole—Angiopathy—Vincristine—colon cancer	0.00525	0.00525	CcSEcCtD
Tinidazole—Flushing—Irinotecan—colon cancer	0.00523	0.00523	CcSEcCtD
Tinidazole—Ataxia—Capecitabine—colon cancer	0.00513	0.00513	CcSEcCtD
Tinidazole—Angiopathy—Irinotecan—colon cancer	0.00511	0.00511	CcSEcCtD
Tinidazole—Coma—Methotrexate—colon cancer	0.00511	0.00511	CcSEcCtD
Tinidazole—Immune system disorder—Irinotecan—colon cancer	0.00509	0.00509	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00491	0.00491	CcSEcCtD
Tinidazole—Flatulence—Irinotecan—colon cancer	0.00484	0.00484	CcSEcCtD
Tinidazole—Muscle spasms—Irinotecan—colon cancer	0.00472	0.00472	CcSEcCtD
Tinidazole—Bronchospasm—Capecitabine—colon cancer	0.00464	0.00464	CcSEcCtD
Tinidazole—Ill-defined disorder—Irinotecan—colon cancer	0.00455	0.00455	CcSEcCtD
Tinidazole—Vertigo—Vincristine—colon cancer	0.00453	0.00453	CcSEcCtD
Tinidazole—Leukopenia—Vincristine—colon cancer	0.00451	0.00451	CcSEcCtD
Tinidazole—Malaise—Irinotecan—colon cancer	0.00443	0.00443	CcSEcCtD
Tinidazole—Vertigo—Irinotecan—colon cancer	0.00441	0.00441	CcSEcCtD
Tinidazole—Neutropenia—Capecitabine—colon cancer	0.00441	0.00441	CcSEcCtD
Tinidazole—Dysuria—Capecitabine—colon cancer	0.00441	0.00441	CcSEcCtD
Tinidazole—Leukopenia—Irinotecan—colon cancer	0.00439	0.00439	CcSEcCtD
Tinidazole—Convulsion—Vincristine—colon cancer	0.00437	0.00437	CcSEcCtD
Tinidazole—Myalgia—Vincristine—colon cancer	0.00429	0.00429	CcSEcCtD
Tinidazole—Leukopenia—Fluorouracil—colon cancer	0.00421	0.00421	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00417	0.00417	CcSEcCtD
Tinidazole—Discomfort—Irinotecan—colon cancer	0.00413	0.00413	CcSEcCtD
Tinidazole—Neuropathy peripheral—Capecitabine—colon cancer	0.00412	0.00412	CcSEcCtD
Tinidazole—Stomatitis—Capecitabine—colon cancer	0.0041	0.0041	CcSEcCtD
Tinidazole—Urinary tract infection—Capecitabine—colon cancer	0.00409	0.00409	CcSEcCtD
Tinidazole—Convulsion—Fluorouracil—colon cancer	0.00407	0.00407	CcSEcCtD
Tinidazole—Confusional state—Irinotecan—colon cancer	0.00404	0.00404	CcSEcCtD
Tinidazole—Nervous system disorder—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Tinidazole—Thrombocytopenia—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Tinidazole—Myalgia—Fluorouracil—colon cancer	0.004	0.004	CcSEcCtD
Tinidazole—Hyperhidrosis—Vincristine—colon cancer	0.00398	0.00398	CcSEcCtD
Tinidazole—Discomfort—Fluorouracil—colon cancer	0.00395	0.00395	CcSEcCtD
Tinidazole—Nervous system disorder—Irinotecan—colon cancer	0.00393	0.00393	CcSEcCtD
Tinidazole—Thrombocytopenia—Irinotecan—colon cancer	0.00392	0.00392	CcSEcCtD
Tinidazole—Anorexia—Vincristine—colon cancer	0.00392	0.00392	CcSEcCtD
Tinidazole—Hyperhidrosis—Irinotecan—colon cancer	0.00387	0.00387	CcSEcCtD
Tinidazole—Confusional state—Fluorouracil—colon cancer	0.00387	0.00387	CcSEcCtD
Tinidazole—Anorexia—Irinotecan—colon cancer	0.00382	0.00382	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—colon cancer	0.00382	0.00382	CcSEcCtD
Tinidazole—Nervous system disorder—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Tinidazole—Thrombocytopenia—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Tinidazole—Hypoaesthesia—Capecitabine—colon cancer	0.00375	0.00375	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.00375	0.00375	CcSEcCtD
Tinidazole—Pharyngitis—Capecitabine—colon cancer	0.00374	0.00374	CcSEcCtD
Tinidazole—Urinary tract disorder—Capecitabine—colon cancer	0.00373	0.00373	CcSEcCtD
Tinidazole—Insomnia—Vincristine—colon cancer	0.00372	0.00372	CcSEcCtD
Tinidazole—Urethral disorder—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Tinidazole—Paraesthesia—Vincristine—colon cancer	0.00369	0.00369	CcSEcCtD
Tinidazole—Anorexia—Fluorouracil—colon cancer	0.00366	0.00366	CcSEcCtD
Tinidazole—Insomnia—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Tinidazole—Paraesthesia—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Tinidazole—Decreased appetite—Vincristine—colon cancer	0.00358	0.00358	CcSEcCtD
Tinidazole—Dyspnoea—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Tinidazole—Erythema multiforme—Capecitabine—colon cancer	0.00357	0.00357	CcSEcCtD
Tinidazole—Somnolence—Irinotecan—colon cancer	0.00356	0.00356	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Vincristine—colon cancer	0.00355	0.00355	CcSEcCtD
Tinidazole—Fatigue—Vincristine—colon cancer	0.00355	0.00355	CcSEcCtD
Tinidazole—Dyspepsia—Irinotecan—colon cancer	0.00353	0.00353	CcSEcCtD
Tinidazole—Constipation—Vincristine—colon cancer	0.00352	0.00352	CcSEcCtD
Tinidazole—Flushing—Capecitabine—colon cancer	0.0035	0.0035	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0035	0.0035	CcSEcCtD
Tinidazole—Decreased appetite—Irinotecan—colon cancer	0.00348	0.00348	CcSEcCtD
Tinidazole—Insomnia—Fluorouracil—colon cancer	0.00347	0.00347	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.00346	0.00346	CcSEcCtD
Tinidazole—Fatigue—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Tinidazole—Paraesthesia—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Tinidazole—Constipation—Irinotecan—colon cancer	0.00343	0.00343	CcSEcCtD
Tinidazole—Angiopathy—Capecitabine—colon cancer	0.00342	0.00342	CcSEcCtD
Tinidazole—Dyspnoea—Fluorouracil—colon cancer	0.00342	0.00342	CcSEcCtD
Tinidazole—Somnolence—Fluorouracil—colon cancer	0.00341	0.00341	CcSEcCtD
Tinidazole—Immune system disorder—Capecitabine—colon cancer	0.00341	0.00341	CcSEcCtD
Tinidazole—Dyspepsia—Fluorouracil—colon cancer	0.00338	0.00338	CcSEcCtD
Tinidazole—Gastrointestinal pain—Vincristine—colon cancer	0.00336	0.00336	CcSEcCtD
Tinidazole—Decreased appetite—Fluorouracil—colon cancer	0.00333	0.00333	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00331	0.00331	CcSEcCtD
Tinidazole—Feeling abnormal—Irinotecan—colon cancer	0.0033	0.0033	CcSEcCtD
Tinidazole—Malnutrition—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—colon cancer	0.00328	0.00328	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—colon cancer	0.00328	0.00328	CcSEcCtD
Tinidazole—Gastrointestinal pain—Irinotecan—colon cancer	0.00328	0.00328	CcSEcCtD
Tinidazole—Abdominal pain—Vincristine—colon cancer	0.00325	0.00325	CcSEcCtD
Tinidazole—Body temperature increased—Vincristine—colon cancer	0.00325	0.00325	CcSEcCtD
Tinidazole—Flatulence—Capecitabine—colon cancer	0.00324	0.00324	CcSEcCtD
Tinidazole—Dysgeusia—Capecitabine—colon cancer	0.00322	0.00322	CcSEcCtD
Tinidazole—Abdominal pain—Irinotecan—colon cancer	0.00317	0.00317	CcSEcCtD
Tinidazole—Body temperature increased—Irinotecan—colon cancer	0.00317	0.00317	CcSEcCtD
Tinidazole—Feeling abnormal—Fluorouracil—colon cancer	0.00316	0.00316	CcSEcCtD
Tinidazole—Muscle spasms—Capecitabine—colon cancer	0.00316	0.00316	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—colon cancer	0.00313	0.00313	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0031	0.0031	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—colon cancer	0.00305	0.00305	CcSEcCtD
Tinidazole—Ill-defined disorder—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Tinidazole—Urticaria—Fluorouracil—colon cancer	0.00305	0.00305	CcSEcCtD
Tinidazole—Body temperature increased—Fluorouracil—colon cancer	0.00303	0.00303	CcSEcCtD
Tinidazole—Hypersensitivity—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Tinidazole—Sweating—Methotrexate—colon cancer	0.003	0.003	CcSEcCtD
Tinidazole—Malaise—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Tinidazole—Vertigo—Capecitabine—colon cancer	0.00295	0.00295	CcSEcCtD
Tinidazole—Hypersensitivity—Irinotecan—colon cancer	0.00295	0.00295	CcSEcCtD
Tinidazole—Asthenia—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Tinidazole—Leukopenia—Capecitabine—colon cancer	0.00294	0.00294	CcSEcCtD
Tinidazole—Palpitations—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Tinidazole—Asthenia—Irinotecan—colon cancer	0.00287	0.00287	CcSEcCtD
Tinidazole—Hypersensitivity—Fluorouracil—colon cancer	0.00283	0.00283	CcSEcCtD
Tinidazole—Diarrhoea—Vincristine—colon cancer	0.00281	0.00281	CcSEcCtD
Tinidazole—Myalgia—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Tinidazole—Arthralgia—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—colon cancer	0.00279	0.00279	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—colon cancer	0.00277	0.00277	CcSEcCtD
Tinidazole—Discomfort—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Tinidazole—Diarrhoea—Irinotecan—colon cancer	0.00274	0.00274	CcSEcCtD
Tinidazole—Dizziness—Vincristine—colon cancer	0.00272	0.00272	CcSEcCtD
Tinidazole—Pruritus—Fluorouracil—colon cancer	0.00271	0.00271	CcSEcCtD
Tinidazole—Confusional state—Capecitabine—colon cancer	0.0027	0.0027	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—colon cancer	0.00266	0.00266	CcSEcCtD
Tinidazole—Dizziness—Irinotecan—colon cancer	0.00265	0.00265	CcSEcCtD
Tinidazole—Nervous system disorder—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Tinidazole—Diarrhoea—Fluorouracil—colon cancer	0.00262	0.00262	CcSEcCtD
Tinidazole—Thrombocytopenia—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Tinidazole—Vomiting—Vincristine—colon cancer	0.00261	0.00261	CcSEcCtD
Tinidazole—Skin disorder—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Tinidazole—Rash—Vincristine—colon cancer	0.00259	0.00259	CcSEcCtD
Tinidazole—Hyperhidrosis—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Tinidazole—Dermatitis—Vincristine—colon cancer	0.00259	0.00259	CcSEcCtD
Tinidazole—Headache—Vincristine—colon cancer	0.00258	0.00258	CcSEcCtD
Tinidazole—Anorexia—Capecitabine—colon cancer	0.00256	0.00256	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Tinidazole—Vomiting—Irinotecan—colon cancer	0.00255	0.00255	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—colon cancer	0.00254	0.00254	CcSEcCtD
Tinidazole—Dizziness—Fluorouracil—colon cancer	0.00254	0.00254	CcSEcCtD
Tinidazole—Rash—Irinotecan—colon cancer	0.00253	0.00253	CcSEcCtD
Tinidazole—Dermatitis—Irinotecan—colon cancer	0.00252	0.00252	CcSEcCtD
Tinidazole—Headache—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—colon cancer	0.00245	0.00245	CcSEcCtD
Tinidazole—Nausea—Vincristine—colon cancer	0.00244	0.00244	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Tinidazole—Vomiting—Fluorouracil—colon cancer	0.00244	0.00244	CcSEcCtD
Tinidazole—Insomnia—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Tinidazole—Rash—Fluorouracil—colon cancer	0.00242	0.00242	CcSEcCtD
Tinidazole—Dermatitis—Fluorouracil—colon cancer	0.00242	0.00242	CcSEcCtD
Tinidazole—Paraesthesia—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Tinidazole—Headache—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Tinidazole—Dyspnoea—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Tinidazole—Nausea—Irinotecan—colon cancer	0.00238	0.00238	CcSEcCtD
Tinidazole—Dyspepsia—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Tinidazole—Decreased appetite—Capecitabine—colon cancer	0.00233	0.00233	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Tinidazole—Fatigue—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Tinidazole—Constipation—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Tinidazole—Nausea—Fluorouracil—colon cancer	0.00228	0.00228	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Tinidazole—Feeling abnormal—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Tinidazole—Malaise—Methotrexate—colon cancer	0.00221	0.00221	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—colon cancer	0.0022	0.0022	CcSEcCtD
Tinidazole—Gastrointestinal pain—Capecitabine—colon cancer	0.00219	0.00219	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—colon cancer	0.00219	0.00219	CcSEcCtD
Tinidazole—Urticaria—Capecitabine—colon cancer	0.00213	0.00213	CcSEcCtD
Tinidazole—Abdominal pain—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Tinidazole—Body temperature increased—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—colon cancer	0.00212	0.00212	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—colon cancer	0.00201	0.00201	CcSEcCtD
Tinidazole—Hypersensitivity—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—colon cancer	0.00193	0.00193	CcSEcCtD
Tinidazole—Asthenia—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Tinidazole—Pruritus—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Tinidazole—Diarrhoea—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Tinidazole—Dizziness—Capecitabine—colon cancer	0.00177	0.00177	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—colon cancer	0.00176	0.00176	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—colon cancer	0.00173	0.00173	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Tinidazole—Vomiting—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Tinidazole—Rash—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Tinidazole—Dermatitis—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Tinidazole—Headache—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—colon cancer	0.00164	0.00164	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—colon cancer	0.00163	0.00163	CcSEcCtD
Tinidazole—Nausea—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—colon cancer	0.00159	0.00159	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—colon cancer	0.00141	0.00141	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Tinidazole—Rash—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Tinidazole—Headache—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Tinidazole—Nausea—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
